Descripción de negocio
Through cutting-edge science and medicine, Biogen discovers, develops and delivers worldwide innovative therapies for people living with serious neurological, autoimmune and rare diseases. Founded in 1978, Biogen is one of the world’s oldest independent biotechnology companies and patients worldwide benefit from its leading multiple sclerosis and innovative hemophilia therapies.
Consejo de gestión & Consejo de supervisión
| CEO |
| Christopher A. Viehbacher |
| Consejo de gestión |
| Michael McDonnell, Dr. Ginger Gregory, Rachid Izzar, Susan H. Alexander, Nicole Murphy, Priya Singhal |
| Consejo de supervisión |
| Caroline Dorsa, Eric K. Rowinsky, Jesus B. Mantas, Maria C. Freire, Stephen A. Sherwin, William A. Hawkins, Susan Langer, Christopher A. Viehbacher, Lloyd B. Minor |
Datos de la empresa
| Nombre: |
Biogen Inc. |
| Dirección: |
225 Binney Street,Cambridge, Massachusetts 02142, USA |
| Teléfono: |
+1 781-464-2000 |
| Fax: |
+1-617-679-2617 |
| E-mail: |
-
|
| Internet: |
www.biogen.com |
| Industria: |
Biotechnology |
| Sector: |
Biotechnology |
| Subsector: |
Biotechnology |
| Fin del año financiero: |
31/12 |
| Acciones de libre circulación: |
72.20% |
| Fecha de OPI: |
- |
Relación con inversores
| Nombre: |
Karen Jewell |
| IR teléfono: |
781-464-2442 |
| IR-fax: |
- |
| IR e-mail: |
IR@biogenidec.com
|
